Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) is a publicly traded the market company. As of October 28, 2026, LABT trades at $0.26 with a market cap of $1.16M and a P/E ratio of 0.00. LABT moved -35.87% today. Year to date, LABT is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.28 to $98.20. Rallies surfaces LABT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for LABT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.26 |
| Market Cap | $1.16M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $98.20 |
| 52-Week Low | $0.28 |
| Volume | 38.28M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
LABT analyst coverage data. Average price target: $0.00.